| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Annovis Bio, Inc. (ANVS) has 5 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. ANVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.57M | $5.84M | - | |
| CEO | 1.21M | $2.75M | - | |
| Dir | 9.3K | $21.1K | - | |
| VP | 500 | $1.1K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Hoffman Michael B | Director | Buy | 45,000 | $4.31 | $193,794.00 | +0.9% | -40.2% | - | |
| Nov 24, 2025 | Hoffman Michael B | Director | Buy | 39,200 | $4.08 | $159,886.07 | +0.4% | -41.6% | - | |
| Nov 21, 2025 | Hoffman Michael B | Director | Buy | 20,000 | $3.50 | $69,900.00 | +0.4% | -36.4% | - | |
| Nov 14, 2025 | Hoffman Michael B | Director | Buy | 15,000 | $2.11 | $31,650.00 | +0.6% | +3.8% | - | |
| Oct 28, 2025 | MacCecchini Maria-Luisa | President &CEO | Buy | 97,561 | $2.05 | $200,000.05 | +8.8% | +41.0% | - | |
| Oct 28, 2025 | Hoffman Michael B | Director | Buy | 975,610 | $2.05 | $2,000,000.50 | +65.9% | +41.0% | - | |
| Oct 12, 2021 | White Mark K. | Director | Buy | 5,000 | $27.40 | $137,000.00 | +9.8% | -39.2% | -53.9% | |
| Oct 11, 2021 | Bruck Claudine | Director | Buy | 181 | $27.66 | $5,006.46 | +3.1% | -38.8% | -53.2% | |
| Oct 11, 2021 | MacCecchini Maria-Luisa | President And CEO | Buy | 18,000 | $27.61 | $496,980.00 | +1.9% | -38.8% | -53.2% | |
| Aug 19, 2021 | McCarthy Reid | Director | Buy | 500 | $37.61 | $18,805.00 | +7.9% | -19.6% | -68.1% |